Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 28 of 28 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 05/07/15
End: 10/02/15
Due: 10/02/16
Phase: N/A
Priority: Normal
Start: 01/08/20
End: 07/20/20
Due: 07/20/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years | NCT00799864 | Janssen Sciences Ireland UC | user2@example.com | None | 2011-01-31 | 2022-08-31 | 2023-08-31 | - | - | 2025-07-14 |
| Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. | NCT02387606 | Janssen Sciences Ireland UC | user2@example.com | None | 2015-05-07 | 2015-10-02 | 2016-10-02 | - | - | 2025-07-14 |
| A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989 | NCT04208386 | Janssen Sciences Ireland UC | user2@example.com | None | 2020-01-08 | 2020-07-20 | 2021-07-20 | - | - | 2025-07-14 |